In this article, we will look at the 12 Stocks That Will Make You Rich in 10 Years.

One of the most read (and recommended) books on investing is Benjamin Graham’s The Intelligent Investor. Among many others, long-term investing is a foundational theme in the book. Graham’s entire framework, from the concept of “Mr. Market” to the “margin of safety,” is designed to help investors think in years, not days.

Even Warren Buffett, the legendary investor and former head of Berkshire Hathaway, thinks the long-term investing strategy is a great approach. In a 2023 CNBC interview, Buffett advised, “Buy wonderful companies at fair prices and hold them for the long term.” He argued that long-term investing minimizes transaction costs, reduces emotional decision-making, and allows investors to benefit from compounding. He’s also been quoted as saying, “The stock market is a device for transferring money from the impatient to the patient.”

Many billionaire investors share Buffett’s position. For example, Fidelity Magellan Fund’s Peter Lynch emphasizes that retail investors can succeed by holding growth stocks for the long term. He’s quoted saying, “People who succeed in the stock market accept periodic losses and stay in the game.” David Booth of Dimensional Fund Advisors told Yahoo Finance that investors should stay invested through market noise, focusing on diversified, low-cost portfolios.

Our Methodology

To compile our list of the 12 stocks that will make you rich in 10 years, we sought companies with strong long-term growth potential and robust investor interest. We used the search term “stocks with high growth potential for the next decade” and analyzed financial media reports, analyst insights, and various online resources to create an initial pool of over 30 promising stocks. Next, we narrowed the list by identifying the 12 stocks most favored by institutional investors. To do this, we analyzed hedge fund sentiment data from Insider Monkey’s Q1 2025 database, which tracks the holdings of more than 1,000 elite hedge funds. Finally, we ranked the 12 stocks in ascending order based on the number of hedge funds that held positions in them as of Q1 2025.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).

Stocks That Will Make You Rich in 10 Years

12. SAP SE (NYSE:SAP)

Number of Hedge Fund Holders: 33

SAP SE (NYSE:SAP) is one of the 12 stocks that will make you rich in 10 years. On June 23, SAP Taulia, a subsidiary of SAP SE, announced a partnership with PayMate, a business-to-business (B2B) payment solutions provider. According to the agreement, PayMate’s payment infrastructure has been made available to SAP Taulia’s customers.

The integration will allow users to access a broader range of payment options, including bank transfers and virtual card payments. For instance, suppliers can now receive virtual card payments directly into their bank accounts without requiring manual intervention. The partnership also enables businesses to leverage their existing credit lines to optimize working capital, streamline supplier payments, and enhance overall financial efficiency.

SAP Taulia stated that businesses will benefit from the improved platform, which will provide greater control and visibility in their financial operations. Additionally, the new platform streamlines payment processes and enhances payment security.

Danielle Weinblatt, Chief Product Officer at SAP Taulia, stated that the partnership provides customers with “future-forward ways to manage supplier payments” and strengthens their ability to offer flexible and efficient solutions across geographies. She emphasized unlocking liquidity trapped in supply chains.

SAP SE (NYSE:SAP) is a German enterprise software company. It develops and sells cloud-based and on-premise solutions that help businesses manage operations like finance, supply chain, HR, and customer experience. Its core products include SAP S/4HANA (ERP), SuccessFactors (HR), Ariba (procurement), Concur (travel and expense), and SAP Analytics Cloud.

11. AstraZeneca PLC (NASDAQ:AZN)

Number of Hedge Fund Holders: 56

AstraZeneca PLC (NASDAQ:AZN) is one of the 12 stocks that will make you rich in 10 years. On June 23, the company announced that the FDA had granted accelerated approval to Datroway for the treatment of adult patients with non-small cell lung cancer (NSCLC).

Datroway is the first and only TROP2-directed antibody-drug conjugate (ADC) approved in the U.S. for lung cancer. The drug is jointly developed and commercialized by AstraZeneca and Daiichi Sankyo. The companies signed a global collaboration agreement in July 2020, valued at up to $6 billion. As part of the agreement, Daiichi Sankyo maintains exclusive rights in Japan, while both companies share responsibilities elsewhere.

The approval followed a Priority Review and Breakthrough Therapy Designation by the FDA, reflecting the drug’s potential to address an unmet medical need. Continued approval may depend on verification of clinical benefit in a confirmatory trial, as is standard for accelerated approvals. Following the approval, AstraZeneca will pay Daiichi Sankyo a $45 million milestone payment for the NSCLC indication, as stipulated in their 2020 collaboration agreement.

AstraZeneca PLC (NASDAQ:AZN) is a global biopharmaceutical company. It discovers, develops, manufactures, and markets prescription medicines across disease areas like oncology, cardiovascular, renal and metabolism, respiratory, immunology, vaccines, and rare diseases. Its leading products include Tagrisso, Imfinzi, Farxiga, Brilinta, Symbicort, and Soliris.